@NovoNordisk l Corporate Vice President 👉 Corporate Communication l Tweets in DK/ENG l Opinions my own l For media requests, see link below👇" title="" class="btn" data-container="body" data-html="true" data-id="35707" data-placement="top" data-toggle="popover" data-trigger="focus" style="color:#b3d4fc" tabindex="0" data-original-title="Katrine Sperling"> 508 222 23,937 199 616 2,059 1,561 45,714 437 1,094 500 2,436 2,233 5,781 2,200,970
Sectors
Location
Bagsværd Torv, 2880 Bagsværd, Denmark
Bagsværd
Denmark
Engaged entities
1425Added in Motherbase
29 Apr 2019, 3:39 p.m.Get updates around our progress and challenges to champion long-term health đź’™ #DrivingChange
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 66,000 people in 80 countries and markets its products in around 170 countries. For more information visit novonordisk.com.
This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to remove those that are off-topic, abusive or intended to spam.
Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in:
https://www.novonordisk.com/contact-us/find-local-information.html
For other customer complaints, please contact us here:
https://www.novonordisk.com/contact-us.html
Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed.
Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users.
Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html
Pharmaceuticals, Insulin, obesity, Rare Diseases, and Diabetes
Novo Nordisk | driving change to defeat serious chronic diseases
Entity | Type | Tweets | Articles | |
---|---|---|---|---|
![]() | Istituto Italiano di Tecnologia Research Services, deeptech | Other | ||
![]() | Lægemiddelstyrelsen (Danish Medicines Agency) | Other 3 Feb 2025 | | |
![]() | Upstream Nexus Executive Offices, it services | Other 12 Jan 2025 | | |
![]() | Active Ageing Association IT Services and IT Consulting | Other 3 Feb 2025 | | |
![]() | FundaciĂłn Humanizando la Sanidad Hospitals and Health Care, healthtech | Other 1 Feb 2025 | | |
![]() | The Skill it services | Other 4 Feb 2025 | | |
![]() | AXON Public Relations and Communications Services, healthtech | Other 29 Jan 2025 | | |
![]() | One Health healthtech | Other 31 Jan 2025 | | |
![]() | Novo Holdings | Other 31 Dec 2024 | | |
![]() | LaunchBio Inc. Biotechnology Research | Other 10 Jan 2025 | |